Catapult Venture Managers has invested £500,000 into Probe Scientific as part of a £1m funding round.
Probe Scientific is developing disposable blood sampling products to solve clinical problems and improve healthcare.
The Bedforshire-based company is said to have a substantial product pipeline based on its proprietary technologies and is seeking to commercialise this range.
MicroEye, Probe’s first product, allows for continuous, automated and real-time sampling without removing blood from the patient.
The device incorporates a semi-permeable membrane, which sits in the vein of a patient, and a biosensor located outside the body to measure blood characteristics such as glucose, potassium and urea levels.